The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
The farnesoid X receptor (FXR) is a bile acid-regulated nuclear receptor expressed in enterohepatic tissues. In this study we investigated whether FXR is expressed by cells of innate immunity and regulates inflammation in animal models of colitis. Acute (7 days) and chronic (8 wk) colitis were induced in wild-type and FXR−/− mice by intrarectal administration of trinitrobenzensulfonic acid or by 7-day administration of 5% dextran sulfate in drinking water. The results of this experiment demonstrate that FXR is expressed by and exerts counterregulatory effects on cells of innate immunity. Exposure of LPS-activated macrophages to 6-ethyl chenodeoxycholic acid (6E-CDCA; INT-747) a synthetic FXR ligand, results in a reciprocal regulation of NF-κB dependent-genes (TNF-α, IL-1β, IL-6, COX-1, COX-2, and iNOS) and induction of SHP, a FXR-regulated gene. FXR activation stabilizes the nuclear corepressor NCoR on the NF-κB responsive element on the IL-1β promoter. Colon inflammation in Crohn’s disease patients and in rodent models of colitis is associated with a reduced expression of FXR mRNA. Using two rodent models of colon inflammation, we show that progression of these immune-mediated disorders is exacerbated in FXR−/− mice (p < 0.01). In vivo treatment with INT-747 attenuates organ injury and immune cell activation. FXR activation increased the colon expression of I-BABP, FXR, and SHP while reducing IL-1β, IL-2, IL-6, TNF-α, and IFN-γ mRNA expression and attenuating disease severity. In aggregate, these findings provide evidence that FXR is an essential component of a network of nuclear receptors that regulate intestinal innate immunity and homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FXR is implicated in intestinal immunomodulation and barrier function (Vavassori et al., 2009).”
From Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway (2023) · cites this paper as Vavassori et al., 2009
In the citing paper
“An additional benefit of FXR activation in the intestine is based on intestinal immunity modulation and decreased ileal bacterial invasion.[80,81]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [80]
In the citing paper
“treatment with a synthetic agonist of BAR has protective effects in mouse models of colitis, whereas BAR-deficient (Nr1h4−/−) mice exhibit exacerbated pathology (Gadaleta et al., 2011; Vavassori et al., 2009).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Vavassori et al., 2009
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
The Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Cited by
Items 501–600 of 657
Taurocholate uptake by Caco-2 cells is inhibited by pro-inflammatory cytokines and butyrate
Couto, M., Andrade, N., Magro, F., & Martel, F. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156307 · Cited by 5
How do different bile acid derivatives affect rat macrophage function – Friends or foes?
Stojanović, N. M., Randjelović, P. J., Maslovarić, A., Kostić, M. S., Raičević, V., Sakač, M. N., & Bjedov, S. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110688 · Cited by 5
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00003-x · Cited by 5
Sahu, R., Mishra, R., & Majee, C. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1797485 · Cited by 5
Makishima, M., & Yamada, S. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10079-4 · Cited by 5
Israelian, N., & Danska, J. S. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-70178-3_7 · Cited by 5
Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer
Keane, J. M., Joyce, S. A., Gahan, C. G. M., Hyland, N. P., & Houston, A. M. (2020) · Results and problems in cell differentiation · doi:10.1007/978-3-030-51849-3_22 · Cited by 5
Young, W., Jester, T., Stoll, M. L., & Ízcue, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-79026-8_19 · Cited by 5
Role of the intestinal microbiota in sepsis-associated encephalopathy
Zhang, M. M., Xiao, D., He, T., Guo, L., & Yang, X. (2025) · Burns & Trauma · doi:10.1093/burnst/tkaf070 · Cited by 4
Barnault, R., Inés, V.-N., Lotteau, V., Durantel, D., & Ramière, C. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106223 · Cited by 6
Divergent metabolic rewiring shapes altered innate immunity
Liu, M., Wang, X., Qu, X., Wang, Y., Shen, X., & Xu, L. (2025) · Cellular Immunology · doi:10.1016/j.cellimm.2025.105025 · Cited by 6
Liu, C., Ma, Q., Liu, J., Sun, Q., Li, Z., Yang, Y., & Rong, R. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115745 · Cited by 4
Biagioli, M., Giorgio, C. D., Marchianò, S., Sensini, B., Urbani, G., Giannelli, E., Lachi, G., Massa, C., Sette, M. R., Paniconi, F., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2645125 · Cited by 6
Self-citationYao, S., Yagi, S., Ogawa, E., Hirata, M., Miyachi, Y., Iwamura, S., Uozumi, R., Sugimoto, T., Asahara, T., Üemoto, S., et al. (2022) · Transplant International · doi:10.3389/ti.2022.10728 · Cited by 4
Protein SUMOylation and Its Functional Role in Nuclear Receptor Control
Wild, N., Kaiser, C. S., Wunderlich, G., Liebau, E., & Wrenger, C. (2024) · Receptors · doi:10.3390/receptors3030020 · Cited by 6
The Role of Bile Acid Receptors in Chronic Inflammatory Diseases
Park, R., & Ji, J. D. (2017) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2017.24.5.253 · Cited by 4
Steiner, C. A., & Higgins, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90578-5_23 · Cited by 6
Biliary acids as promoters of colon carcinogenesis: a narrative review
Kulanthaivel, S., Boccuto, L., Zanza, C., Longhitano, Y., Balasundaram, K., Méndez‐Sánchez, N., & Abenavoli, L. (2021) · Digestive Medicine Research · doi:10.21037/dmr-21-23 · Cited by 5
Valencia‐Ortega, J., González-Reynoso, R., Salcedo–Vargas, M., Díaz-Velázquez, M. F., Ramos-Martínez, E. G., Ferreira‐Hermosillo, A., Mercado, M., & Saucedo, R. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.02.004 · Cited by 5
Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship
Peviani, M., Cazzagon, N., Gambato, M., Bertin, L., Zingone, F., SAVARINO, E. V., & Barberio, B. (2024) · Minerva Gastroenterology · doi:10.23736/s2724-5985.23.03605-7 · Cited by 7
Neumann, S., Peyroux, E. M., Woodall, M. J., Shields, N. J., Young, S. L., & Pattison, S. T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88137 · Cited by 6
Ceulemans, L. J., Canovai, E., Verbeke, L., Pirenne, J., & Farré, R. (2016) · Acta chirurgica Belgica · doi:10.1080/00015458.2016.1215953 · Cited by 4
Gray, D. W., Welsh, M. D., Mansoor, F., Doherty, S., Chevallier, O. P., Elliott, C. T., & Mooney, M. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194488 · Cited by 6
Dissecting Microscopic Colitis Immunopathophysiology: Insights From Basic Research
Münch, A., & Escudero‐Hernández, C. (2025) · United European Gastroenterology Journal · doi:10.1002/ueg2.70024 · Cited by 4
Vito, F. D., Marasco, R., Suraci, E., Facciolo, A., Hribal, M. L., Sesti, G., Andreozzi, F., Luzza, F., & Fiorentino, T. V. (2025) · Diabetes · doi:10.2337/db25-0035 · Cited by 6
Xu, X., Shang, B., Wu, H., Jin, X., Wang, J., Li, J., Li, D., Liang, B., Wang, X., Su, L., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.190716 · Cited by 3
From Microbial Ecology to Functional Components in Microbe–Host Interactions
Wang, T., Wang, Z., Yang, X., & Zhang, L. (2026) · Biology · doi:10.3390/biology15080635 · Cited by 3
Hintersteininger, M., Schwarz, M., Schwabl, P., Hartl, L., Balcar, L., Hofer, B., Kramer, G., Sebesta, C., Thöne, P., Attalla, P., et al. (2026) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70675 · Cited by 3
Emerging Role of Gut Microbiota in Modulating Response to Therapies in IBD
Bartocci, B., GAUDIO, A. D., Murgiano, M., Papa, A., Cammarota, G., Gasbarrini, A., Scaldaferri, F., & Lopetuso, L. R. (2026) · Microorganisms · doi:10.3390/microorganisms14051082 · Cited by 5
Hua, C., Geng, Y., Chen, Q., Niu, L., Cai, L., Tao, S., Ni, Y., & Zhao, R. (2018) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2018.05.005 · Cited by 3
Non-alcoholic fatty liver disease and intestinal immune status: a narrative review
Wu, H., Lei, Y., & Mao, J. (2022) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2022.2032320 · Cited by 3
Hoang, S. H., Tveter, K. M., Mezhibovsky, E., & Roopchand, D. E. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2224886 · Cited by 3
Genetic dissection of Iddm26 in the spontaneously diabetic BBDP rat
Sarmiento, J., Wallis, R. H., Ning, T., Marandi, L., Chao, G. Y. C., Paterson, A. D., & Poussier, P. (2014) · Genes and Immunity · doi:10.1038/gene.2014.29 · Cited by 3
Developments in understanding bile acid metabolism
Morimoto, K., Itoh, H., & 渡辺, 光. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.75 · Cited by 7
Gut Microbiota and Pancreatobiliary System
Ryu, K.-H. (2020) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2020.75.5.231 · Cited by 4
Prospective role of prebiotics and probiotics in gut immunity
Samanta, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822238-6.00014-5 · Cited by 4
On the Pharmacology of Farnesoid X Receptor Agonists: Give me an "A", Like in "Acid"
Hambruch, E., Kinzel, O., & Kremoser, C. (2016) · Nuclear Receptor Research · doi:10.11131/2016/101207 · Cited by 3
FARNESOID X RECEPTOR AND REPRODUCTION
(2015) · Receptors & Clinical Investigation · doi:10.14800/rci.463 · Cited by 3
Role of Bile Acids and Nuclear Receptors in Acupuncture in Improving Crohn’s Disease
Shen, J., Qi, Q., Han, D., Liu, S., Huang, R., Zhu, Y., Zheng, H., Gu, K., Wu, H., & Liu, H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5814048 · Cited by 3
Temporal Modulation of Gut Microbiome and Metabolome by Morphine
Wang, F. (2015) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 5
Microbiota metabolized Bile Acids accelerate Gastroesophageal Adenocarcinoma via FXR inhibitionPreprint
Baumeister, T., Proaño-Vasco, A., Metwaly, A., Kleigrewe, K., Kuznetsov, A., Schömig, L. R., Borgmann, M., Khiat, M., Anand, A., Böttcher, K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.11.598405 · Cited by 3
Zeise, K. D., Falkowski, N. R., Metcalf, J. D., Brown, C. A., & Huffnagle, G. B. (2024) · Infection and Immunity · doi:10.1128/iai.00438-24 · Cited by 2
Thomas, S., Pike, C. M., Perkins, C. W., Brown, S., Jaen, X. M. E., McMillan, A. S., & Theriot, C. M. (2025) · Infection and Immunity · doi:10.1128/iai.00150-25 · Cited by 2
The Potential Anticancer Mechanisms of Probiotics: A Comprehensive Review
Tang, C., Qian, Y., Jia, S., Zhang, J., Zhang, Y., Ren, Y., Yong, H., Xu, J., Kan, J., & Liu, J. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10753-6 · Cited by 2
Wang, P., Wang, Y., Gao, W., Wang, M., Liu, Y., Feng, L., Yin, H., Chen, M., Zhai, L., Yuan, P., et al. (2026) · Food & Function · doi:10.1039/d5fo05530j · Cited by 2
Kang, D., Li, A. Q., Xie, X., Liu, H., Chen, L., Feng, Z., Gao, X., Gao, H., Wu, X., Lu, H., et al. (2026) · MedComm · doi:10.1002/mco2.70637 · Cited by 3
Yi, L., Song, G., Guan, X., Jia, H., Cheng, W. T. K., Xie, Y., Zhao, Y., Zhu, J., & Zhao, S. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.119897 · Cited by 2
Zhao, S., Zhang, J., Mi, Y., Quan, B., 胡紫娟, Zhong, X., Xu, Y., Cai, S., Li, X., Wei, P., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71403-1 · Cited by 5
Multiple roles of bile acids in ferroptosis regulation: Opportunities for disease therapy
Wu, N., Yu, S., Wei, X., Yang, L., & Zhang, X. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108224 · Cited by 2
The interplay between bile acid metabolism and gut microbiome in biliary tract cancers
Ike, I., Teymouri, F., Crook, C. J., Guzman, S., Hazeltine, M. D., Castillo, D., Li, D., & Brar, G. (2026) · Frontiers in Microbiomes · doi:10.3389/frmbi.2026.1774429 · Cited by 2
Trichuris suis Ova, Lecithin and Other Fancy Molecules
Schölmerich, J. (2014) · Digestive Diseases · doi:10.1159/000367831 · Cited by 2
Bile Acid-Derived Vitamin D Receptor Ligands
Makishima, M., & Yamada, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809963-6.00088-2 · Cited by 2
Ma, W., Zhang, P., Yiming, A., Amuti, S., & Ruze, A. (2022) · Andrologia · doi:10.1111/and.14382 · Cited by 2
Joyce, S. A., & O’Malley, D. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00226.2024 · Cited by 2
Fecal Bile Acids Profile of Crewmembers Consuming the Same Space Food in a Spacecraft Simulator
Dong, H.-S., Shen, Q.-B., Lan, H., Zhao, W. G., Cao, P., & Chen, P. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.593226 · Cited by 1
Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders
Li, F., Chen, Q., Dai, Y., & Lu, L. (2025) · iScience · doi:10.1016/j.isci.2025.114042 · Cited by 1
Gu, Y., Li, Q., Cao, L., & Huabing, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020709 · Cited by 2
High-altitude exposure remodels the gut microbiota: health and disease
Li, Y., Jiang, M., Pang, J., Ma, C., Zhang, H., Yin, F., Jia, Y., Xiang, Z., Zuo, T., & Zhang, H. (2026) · MedScience · doi:10.1007/s11684-026-1206-2 · Cited by 2
Yao, S., Yang, L., Wang, S. K., Shen, J., Li, Y., Guo, S., Cui, X., Xiao, Z., & Wu, Z. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105413 · Cited by 2
Cagle, R., Proll, S. C., Minot, S. S., Purcell, H. J., Zhu, W., Djukovic, D., Liu, C., Fiedler, T. L., DeMeules, M. M., Mielcarek, M. B., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1818647 · Cited by 1
Bile Acid Receptors and Liver Regeneration
Fan, M., Ding, L., & Huang, W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420128-6.00009-9 · Cited by 1
The Cross Talk Between Bile Acids and Intestinal Microbiota
Fiamoncini, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00014-2 · Cited by 1
Familial Intrahepatic Cholestasis
Grammatikopoulos, T. (2021) · Springer eBooks · doi:10.1007/978-3-030-80068-0_61 · Cited by 2
Kudira, R., Pasula, S., Kapil, S., & Miethke, A. G. (2022) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4400 · Cited by 1
The Role of the Gut Microbiome in Neurological Diseases
Turner, T.-A. J., & Mangalam, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00103-2 · Cited by 3
Rojas‐Juárez, R., Rodríguez‐Castelán, J., Cuatecontzi‐Fuentes, I., Méndez-Tepepa, M., Cruz‐Lumbreras, R., Rodríguez‐Antolín, J., Arroyo-Helguera, O. E., & Cuevas‐Romero, E. (2024) · The Anatomical Record · doi:10.1002/ar.25590 · Cited by 1
Losa, M., Schwarzfischer, M., Emmenegger, M., Spalinger, M. R., Rogler, G., & Scharl, M. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168042 · Cited by 4
Familial Intrahepatic Cholestasis
Grammatikopoulos, T., & Thompson, R. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_58 · Cited by 1
[Farnesoid X receptor regulates glucose and lipid metabolisms].
Jiang, Q., Peng, J., Liu, S., & Shen, Z.-F. (2015) · PubMed · Cited by 1
Investigating Fibroblast Growth Factor 19 expression in primary and secondary bile acid diarrhoea
Nolan, J. (2016) · doi:10.25560/41879 · Cited by 1
Influence of the gut microbiome on plasma metabolite patterns
Behr, C. (2019) · doi:10.18174/463891 · Cited by 1
Transactivation versus transrepression in FXR: lessons learned from other Nuclear Receptors
Hollman, D. A. A. (2011) · Utrecht University Repository (Utrecht University)
Vaquero, J. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.121427 · Cited by 2
Jakobsson, T. (2011) · Figshare · Cited by 1
The role of the farnesoid X receptor in metabolic control
Stroeve, J. H. M. (2011) · University of Groningen research database (University of Groningen / Centre for Information Technology)
New insights into inflammatory bowel disease and colitis-associated neoplasia
van Schaik, F. D. M. (2012) · Utrecht University Repository (Utrecht University)
Thomas, A. (2011) · KU ScholarWorks (The University of Kansas)
Kayama, H., & Takeda, K. (2015) · Inflammation and Regeneration · doi:10.2492/inflammregen.35.028
Gene selective regulation by hepatic Farnesoid x receptor (fxr) in health and disease
Lee, J. (2011) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Gut microbial regulation of bile acid metabolism and signaling
Sayin, S. I. (2016) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Farnesoid X receptor activation regulates vascular tension of rat mesenteric resistance arteries
Zhang, R., Ran, H. H., Peng, L., Zhao, Y. C., Sun, T., & Shen, B. (2016) · European Journal of BioMedical Research · doi:10.18088/ejbmr.2.3.2016.pp1-6
Makishima, M. (2017) · Springer eBooks · doi:10.1007/978-4-431-56062-3_4
Kitamura, T., & Watanabe, S. (2017) · Springer eBooks · doi:10.1007/978-4-431-56062-3_10
Biotransformation by the Gut Microbiome
Chi, L., & Lü, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64268-x · Cited by 1
Role of intestinal microflora in the regulation of immune response in rheumatoid arthritis
Podolinskaya, N., & Vykhrystsenka, I. (2017) · Immunopathology Allergology Infectology · doi:10.14427/jipai.2017.1.37
Oliphant, K. (2018) · The Atrium (University of Guelph) · Cited by 1
The Microbiota and Ovarian Cancer
Tanyi, J. L., & Facciabene, A. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_11
Studies on the pathophysiology of bile acid-induced inflammatory airways disease
Aldhahrani, A. (2017)
The Interaction of Nutrition with Nuclear Receptors in Obesity and Diabetes
Tovar‐Palacio, C., Noriega, L. G., Torre-Villalvazo, I., Díaz‐Villaseñor, A., & Palacios‐González, B. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160608-00094
Bile Acids and Bilirubin in Liver Immunology
Zhu, C., Claudel, T., & Trauner, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_7 · Cited by 1
Diet, Microbioma, and Diabetes in Aging
Fernández, S. S. M., & Ribeiro, S. M. L. (2020) · Current Geriatrics Reports · doi:10.1007/s13670-020-00339-1 · Cited by 1
Endoplasmic reticulum stress in intestinal inflammation: implications of bile acids
Eugene, S. P., & Trinath, J. (2021) · Proceedings of the Indian National Science Academy · doi:10.1007/s43538-021-00031-8
You, Y. N., & Bednarski, B. K. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717969142.793471431
Qiu, Y., Li, K., Liu, S., Wang, L., Gao, K., Yang, X., & Jiang, Z. (2020) · doi:10.21203/rs.3.rs-32927/v1
Regulation of Immune Cell Functions by Bile Acid-Activated ReceptorsPreprint
Cheung, K. C. P., Jiao, M. A., Loiola, R. A., Chen, X., & Jia, W. P. (2022) · doi:10.22541/au.166899605.52123374/v1
Precision Nutrition and Metabolomics, a Model of Alzheimer’s Disease
Ledinger, S., Ludwig-Papst, C., & Scheffler, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-10153-3_7
The gut microbiota: A driver of Type 2 diabetes
Scheithauer, T. P. M. (2023) · doi:10.5463/thesis.82
Epigenetic regulation in trained and tolerized macrophages
Benjaskulluecha, S. (2022) · Chula Digiverse · doi:10.58837/chula.the.2022.236
Rakić, M., Repac, J., Lunić, T. M., Božić, B. D., & Nedeljković, B. B. (2023) · Arhiv za farmaciju · doi:10.5937/arhfarm73-46395 · Cited by 1
Metadata
- Authors
- Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- Azienda Ospedaliera di Perugia (IT)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 183
- Issue
- 10
- Pages
- 6251-6261
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2125524268
- Cited by
- 655
- References
- 34
- Citations by year
- 2026: 42 · 2025: 51 · 2024: 49 · 2023: 52 · 2022: 71 · 2021: 56 · 2020: 55 · 2019: 40 · 2018: 34 · 2017: 36 · 2016: 31 · 2015: 31 · 2014: 25 · 2013: 22 · 2012: 25
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- farnesoid X receptor, intestinal innate immunity, colitis, Crohn's disease, NF-κB, SHP, NCoR, macrophages, chenodeoxycholic acid, trinitrobenzene sulfonic acid, dextran sulfate, TNF-α, IL-1β, interleukin-6, intestinal inflammation, nuclear receptors, intestinal homeostasis
- MeSH terms
- Receptor, Farnesoid X-Activated, Acute Disease, Adult, Animals, Chronic Disease, Colitis, Crohn Disease, Female, Humans, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Macrophages, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Trinitrobenzenesulfonic Acid, NF-kappa B, Mice, SCID, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Mice, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.